These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2878831)

  • 21. Antibiotics of choice against Bacteroides fragilis.
    Bittner J; Voinescu V; Munteanu V; Antohi M; Ardeleanu J
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):213-8. PubMed ID: 7159211
    [No Abstract]   [Full Text] [Related]  

  • 22. Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates.
    Schaumann R; Petzold S; Fille M; Rodloff AC
    Infection; 2005 Oct; 33(5-6):368-72. PubMed ID: 16258869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro antibiotic susceptibility of Bacteroides fragilis strains isolated from excised appendix of patients with phlegmonous or gangrenous appendicitis.
    Wójcik-Stojek B; Bulanda M; Martirosian G; Heczko P; Meisel-Mikołajczyk F
    Acta Microbiol Pol; 2000; 49(2):171-5. PubMed ID: 11093680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro activity of cefotaxime on anaerobes (author's transl)].
    Soussy CJ; Thibault M; Duval J
    Nouv Presse Med; 1981 Feb; 10(8):556-8. PubMed ID: 6259592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Action of a metronidazole-spiramycin association on anaerobic bacteria].
    Videau D
    Pathol Biol (Paris); 1971; 19(11):661-6. PubMed ID: 4326560
    [No Abstract]   [Full Text] [Related]  

  • 26. Antimicrobial activity of SMAP-29 against the Bacteroides fragilis group and clostridia.
    Arzese A; Skerlavaj B; Tomasinsig L; Gennaro R; Zanetti M
    J Antimicrob Chemother; 2003 Sep; 52(3):375-81. PubMed ID: 12917245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983.
    Nord CE; Olsson-Liljequist B
    Scand J Infect Dis Suppl; 1984; 43():44-9. PubMed ID: 6100139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro effect of metronidazole and tinidazole on anaerobic bacteria.
    Dornbusch K; Nord CE
    Med Microbiol Immunol; 1974; 160(4):265-7. PubMed ID: 4375789
    [No Abstract]   [Full Text] [Related]  

  • 29. [Sensitivity of strict anaerobic bacteria to metronidazole, cefoxitin, and clindamycin].
    Dubreuil L; Derriennic M; Reynaud A; Devos J; Romond C; Courtieu A
    Pathol Biol (Paris); 1985 Nov; 33(9):899-903. PubMed ID: 3909082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Activity of seven antimicrobial agents against "Bacteroides fragilis" (author's transl)].
    Tytgat F
    Ann Microbiol (Paris); 1980; 131(1):39-44. PubMed ID: 6899739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)].
    Rokosz A; Pawłowska J; Sawicka-Grzelak A; Luczak M
    Med Dosw Mikrobiol; 2004; 56(3):245-53. PubMed ID: 15773501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The incidence and significance of Streptococcus sanguis, Streptococcus mutans and Streptococcus salivarlius in root canal cultures from human teeth.
    Mejåre B
    Odontol Revy; 1974; 25(4):359-77. PubMed ID: 4532212
    [No Abstract]   [Full Text] [Related]  

  • 33. Emergence of antibiotic resistant strains of Bacteroides fragilis.
    Scher KS
    Surg Gynecol Obstet; 1988 Sep; 167(3):175-9. PubMed ID: 3413646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential gene expression in a Bacteroides fragilis metronidazole-resistant mutant.
    Diniz CG; Farias LM; Carvalho MA; Rocha ER; Smith CJ
    J Antimicrob Chemother; 2004 Jul; 54(1):100-8. PubMed ID: 15150173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The comparative in vitro activity of ofloxacin (RU 43 280) and other quinolone derivatives against 722 bacteria of clinical interest.
    Santos Ferreira M; Vital J
    Chemioterapia; 1987 Jun; 6(2 Suppl):145-7. PubMed ID: 2908239
    [No Abstract]   [Full Text] [Related]  

  • 36. Laboratory diagnosis of antibiotic-associated diarrhea: a Polish pilot study into the clinical relevance of Clostridium difficile and Clostridium perfringens toxins.
    Pituch H; Obuch-Woszczatyński P; Wultańska D; van Belkum A; Meisel-Mikołajczyk F; Łuczak M
    Diagn Microbiol Infect Dis; 2007 May; 58(1):71-5. PubMed ID: 17300901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of antimicrobial resistance and resistance transfer in anaerobic bacteria.
    Tally FP; Malamy MH
    Scand J Infect Dis Suppl; 1982; 35():37-44. PubMed ID: 6300995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacteraemia due to Bacteroides fragilis with reduced susceptibility to metronidazole.
    Elsaghier AA; Brazier JS; James EA
    J Antimicrob Chemother; 2003 Jun; 51(6):1436-7. PubMed ID: 12746378
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical and bacteriological studies of the effect of Metronidazol (Klion) used in root canal therapy].
    Ferenczi I; Nyárasdy I; Békésy Z
    Fogorv Sz; 1975 Jul; 68(7):201-5. PubMed ID: 1056861
    [No Abstract]   [Full Text] [Related]  

  • 40. [In vitro activity of the amoxicillin-clavulanic acid combination on anaerobic bacteria. Comparison with amoxicillin, lamoxactam and metronidazole].
    Deforges L; Soussy CJ; Duval J
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):540-3. PubMed ID: 6462743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.